ORIC
OricBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade B from latest DB weights. Momentum 74.9 / Value 41.1
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +28.8.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
75
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $20.29
Why
Momentum75 · Δ7d +28.8
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
75
40% active weight
Current posture
7d trendFlat
Δ7d
+28.8
Δ21d
+64.7
Value
41
60% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 74.9 / Value 41.1
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.08B
Beta
1.34
Shares Out
103.52M
P/E (TTM) · Derived
-7.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-8.60
Rev YoY
-
EPS YoY
-19.8%
Gross Margin
-
Op Margin
-
Net Debt
-$274.05M
Current Ratio
16.33
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology